Power Sean A's Form 4 filing
TG Therapeutics, Inc. (TGTX) · filed Jan 7, 2025
- Accession no.
- 0001437749-25-000662
- Filed
- Jan 7, 2025
- Trade date
- Jan 3-6, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $629.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Power Sean ACIK 0001538845 | Officer (CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Common Stock | SSaleDisposed | −11,337 | $30.29 | −$343,397.73 | 670,632 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −10,021 | $28.53 | −$285,899.13 | 660,611 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.